Skip to main content
Springer Nature Link
Log in

Herpes zoster infection in pregnancy: features and consequences

  • REVIEW
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Herpes (varicella) zoster (HZ) infection occurs in 4 people per 1000 in the general US population (irrespective of prior varicella infection and vaccination status) each year and has been the subject of scientific inquiry for decades. The consequences of infection are myriad and may depend on the dermatome of involvement as well as host factors such as age, comorbidities, prior treatment or immunization, and immunologic status. Pregnancy is associated with an altered immune and hormonal status in the mother. While maternal HZ infection during pregnancy is not uncommon, the implications for both mother and child are not well established, although multiple studies of perinatal maternal HZ infection suggest no intrauterine transmission to the fetus. We review the current literature on herpes zoster infection in pregnancy, including epidemiology, diagnosis, potential immunologic sequelae, and strategies for prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention (CDC) (2020) Shingles (Herpes Zoster). In: Shingles home. Avaliable via https://www.cdc.gov/shingles/hcp/clinical-overview.html#:~:text=Disease%20Rates,-An%20estimated%20one&text=The%20incidence%20for%20herpes%20zoster,per%20100%20U.S.%20population%20annually. Accessed Mar 2024

  2. Schmader K (2018) Herpes zoster. Ann Intern Med 169(3):itc19–itc31. https://doi.org/10.7326/aitc201808070

    Article  PubMed  Google Scholar 

  3. Schafer R, Davis M, Phillippi JC (2019) Herpes zoster in pregnancy. J Midwifery Womens Health 64(2):230–235. https://doi.org/10.1111/jmwh.12953

    Article  PubMed  Google Scholar 

  4. Enders G, Miller E (2000) Varicella and herpes zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA (eds) Varicella-zoster virus: virology and clinical management. Cambridge University Press, Cambridge, pp 317–348

    Chapter  Google Scholar 

  5. Kennedy PGE, Mogensen TH, Cohrs RJ (2021) Recent issues in varicella-zoster virus latency. Viruses. https://doi.org/10.3390/v13102018

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kennedy PGE, Gershon AA (2018) Clinical features of varicella-zoster virus infection. Viruses. https://doi.org/10.3390/v10110609

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gershon AA et al (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016. https://doi.org/10.1038/nrdp.2015.16

    Article  PubMed  PubMed Central  Google Scholar 

  8. Centers for Disease Control and Prevention (CDC) (2021) Zoster. In: Epidemiology and prevention of vaccine-preventable diseases. Avaliable via https://www.cdc.gov/vaccines/pubs/pinkbook/herpes-zoster.html#:~:text=The%20first%20vaccine%20to%20reduce,the%20United%20States%20in%202006. Accessed Mar 2024

  9. Harpaz R, Ortega-Sanchez I, Seward J (2008) Advisory committee on immunization practices centers for disease C, prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57(RR-5):1–30

    PubMed  Google Scholar 

  10. Gershon M, Gershon A (2018) Varicella-zoster virus and the enteric nervous system. J Infect Dis 218(suppl_2):S113-s119. https://doi.org/10.1093/infdis/jiy407

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645. https://doi.org/10.1056/nejm200003023420906

    Article  CAS  PubMed  Google Scholar 

  12. Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM (2010) Varicella seroprevalence in the US: data from the National Health and Nutrition Examination Survey, 1999–2004. Public Health Rep 125(6):860–869. https://doi.org/10.1177/003335491012500613

    Article  PubMed  PubMed Central  Google Scholar 

  13. van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, Curran D, Yawn B (2021) A systematic literature review of herpes zoster incidence worldwide. Hum Vaccin Immunother 17(6):1714–1732. https://doi.org/10.1080/21645515.2020.1847582

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mor G, Cardenas I (2010) The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63(6):425–433. https://doi.org/10.1111/j.1600-0897.2010.00836.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Marra F, Parhar K, Huang B, Vadlamudi N (2020) Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infect Dis 7(1):ofaa005. https://doi.org/10.1093/ofid/ofaa005

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lin WC, Wei JC (2023) Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol 95(7):e28903. https://doi.org/10.1002/jmv.28903

    Article  CAS  PubMed  Google Scholar 

  17. Chen YC et al (2023) Long-term risk of herpes zoster following COVID-19: a retrospective cohort study of 2 442 686 patients. J Med Virol 95(4):e28745. https://doi.org/10.1002/jmv.28745

    Article  CAS  PubMed  Google Scholar 

  18. Akpandak I, Miller DC, Sun Y, Arnold BF, Kelly JD, Acharya NR (2022) Assessment of herpes zoster risk among recipients of COVID-19 vaccine. JAMA Netw Open 5(11):e2242240–e2242240. https://doi.org/10.1001/jamanetworkopen.2022.42240

    Article  PubMed  PubMed Central  Google Scholar 

  19. Saguil A, Kane S, Mercado M, Lauters R (2017) "Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Phys 96(10):656–663

    Google Scholar 

  20. Russell LK (1992) Management of varicella-zoster virus infection during pregnancy and the peripartum. J Nurse Midwifery 37(1):17–24. https://doi.org/10.1016/0091-2182(92)90018-x

    Article  CAS  PubMed  Google Scholar 

  21. Sampathkumar P, Drage LA, Martin DP (2009) Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 84(3):274–280. https://doi.org/10.1016/s0025-6196(11)61146-4

    Article  PubMed  PubMed Central  Google Scholar 

  22. Nanthakumar MP, Sood A, Ahmed M, Gupta J (2021) Varicella zoster in pregnancy. Eur J Obstet Gynecol Reprod Biol 258:283–287. https://doi.org/10.1016/j.ejogrb.2021.01.009

    Article  PubMed  Google Scholar 

  23. Paryani SG, Arvin AM (1986) Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 314(24):1542–1546. https://doi.org/10.1056/nejm198606123142403

    Article  CAS  PubMed  Google Scholar 

  24. Mouly F et al (1997) Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 177(4):894–898

    Article  CAS  PubMed  Google Scholar 

  25. Lamont RF et al (2011) Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG 118(10):1155–1162. https://doi.org/10.1111/j.1471-0528.2011.02983.x

    Article  PubMed  PubMed Central  Google Scholar 

  26. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343(8912):1548–1551. https://doi.org/10.1016/s0140-6736(94)92943-2

    Article  CAS  PubMed  Google Scholar 

  27. Blumental S, Lepage P (2019) Management of varicella in neonates and infants. BMJ Paediatr Open 3(1):e000433. https://doi.org/10.1136/bmjpo-2019-000433

    Article  PubMed  PubMed Central  Google Scholar 

  28. Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21(8):545–549. https://doi.org/10.1038/sj.jp.7210599

    Article  CAS  PubMed  Google Scholar 

  29. Centers for Disease Control and Prevention (CDC) (2021) Chickenpox vaccination: what everyone should know. In: Vaccines and preventable diseases. Avaliable via https://www.cdc.gov/vaccines/vpd/varicella/public/index.html. Accessed Mar 2024

  30. ProQuad® [Package insert] (2005) Merck & Co., Inc., Rahway, NJ, USA

  31. Singh T, Otero CE, Li K, Valencia SM, Nelson AN, Permar SR (2020) Vaccines for perinatal and congenital infections-how close are we? Front Pediatr 8:569. https://doi.org/10.3389/fped.2020.00569

    Article  PubMed  PubMed Central  Google Scholar 

  32. M. The Centers for Disease Control and Prevention (CDC) (2021) MMRV (Measles, Rubella & Varicella) VIS. In: Vaccine information statements (VISs). Available via https://www.cdc.gov/vaccines/hcp/vis/vis-statements/mmrv.html. Accessed Mar 2024

  33. Gershon AA, Gershon MD, Shapiro ED (2021) Live attenuated varicella vaccine: prevention of varicella and of zoster. J Infect Dis 224(Supplement_4):S387–S397. https://doi.org/10.1093/infdis/jiaa573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Weinmann S et al (2013) Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 208(11):1859–1868. https://doi.org/10.1093/infdis/jit405

    Article  PubMed  Google Scholar 

  35. Hardy I, Gershon AA, Steinberg SP, LaRussa P (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 325(22):1545–1550. https://doi.org/10.1056/nejm199111283252204

    Article  CAS  PubMed  Google Scholar 

  36. American Society for Reproductive Medicine; American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice (2019) Prepregnancy counseling: committee opinion no. 762. Fertil Steril 111(1):32-42. https://doi.org/10.1016/j.fertnstert.2018.12.003. (PMID: 30611411)

  37. CDC (2022) Guidelines for vaccinating pregnant women. In: pregnancy and vaccination. Available via https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/guidelines.html#18. Accessed Mar 2024

  38. Willis ED, Marko AM, Rasmussen SA, McGee M, Broder KR, Marin M (2022) Merck/Centers for disease control and prevention varicella vaccine pregnancy registry: 19-year summary of data from inception through closure, 1995–2013. J Infect Dis 226(Supplement_4):S441-s449. https://doi.org/10.1093/infdis/jiac277

    Article  PubMed  Google Scholar 

  39. Hayward K, Cline A, Stephens A, Street L (2018) Management of herpes zoster (shingles) during pregnancy. J Obstet Gynaecol 38(7):887–894. https://doi.org/10.1080/01443615.2018.1446419

    Article  PubMed  Google Scholar 

  40. Park TH, Chang CH (2012) Keloid recurrence in pregnancy. Aesthetic Plast Surg 36(5):1271–1272. https://doi.org/10.1007/s00266-012-9947-5

    Article  PubMed  Google Scholar 

  41. Verma SB, Wollina U (2013) Herpes zoster in pregnancy leading to keloids and post herpetic neuralgia: a double whammy? Indian Dermatol Online J 4(2):158–159. https://doi.org/10.4103/2229-5178.110646

    Article  PubMed  PubMed Central  Google Scholar 

  42. Casanova Román G, Reyna Figueroa J, Figueroa Damián R, Ortiz Ibarra J (2004) Herpes zoster in immunocompetent pregnant women and their perinatal outcome. Ginecol Obstet Mex 72:63–67

    PubMed  Google Scholar 

  43. Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2(8659):371–373. https://doi.org/10.1016/s0140-6736(89)90547-3

    Article  CAS  PubMed  Google Scholar 

  44. Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4(4):222–230

    Article  Google Scholar 

  45. Quenby S et al (2021) Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet 397(10285):1658–1667. https://doi.org/10.1016/s0140-6736(21)00682-6

    Article  CAS  PubMed  Google Scholar 

  46. (2023) Herpes zoster (Shingles). In: Mother to baby | Fact Sheets [Internet]. Organization of teratology information specialists (OTIS), Brentwood (TN), 1994–. (PMID: 35952020)

  47. Higa K, Dan K, Manabe H (1987) Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet Gynecol 69(2):214–222

    CAS  PubMed  Google Scholar 

  48. Dworkin RH et al (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44(Suppl 1):S1-26. https://doi.org/10.1086/510206

    Article  CAS  PubMed  Google Scholar 

  49. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB (2000) Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 182(1 Pt 1):159–163. https://doi.org/10.1016/s0002-9378(00)70506-0

    Article  CAS  PubMed  Google Scholar 

  50. Stone KM et al (2004) Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984–1999. Birth Defects Res A Clin Mol Teratol 70(4):201–207. https://doi.org/10.1002/bdra.20013

    Article  CAS  PubMed  Google Scholar 

  51. Pasternak B, Hviid A (2010) Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA 304(8):859–866. https://doi.org/10.1001/jama.2010.1206

    Article  CAS  PubMed  Google Scholar 

  52. LIDODERM (Lidocaine Patch 5%) [Package insert] (2014) Endo Pharmaceuticals Inc., Malvern, PA

  53. Kim JY, Ko YR, Sim SE, Oh S, Lee MH, Park HJ (2020) Safe drug treatment and procedure for herpes zoster in pregnancy: a case report. Chin Med J (Engl) 133(16):1999–2000. https://doi.org/10.1097/cm9.0000000000000927

    Article  PubMed  Google Scholar 

  54. Sadati MS, Ahrari I (2014) Severe herpes zoster neuralgia in a pregnant woman treated with acetaminophen. Acta Med Iran 52(3):238–239

    PubMed  Google Scholar 

  55. Wong JW, Chin JM, Schlueter RJ (2018) Shingles in pregnancy: an elusive case of left upper quadrant abdominal pain. Hawaii J Med Public Health 77(8):179–182

    PubMed  PubMed Central  Google Scholar 

  56. Stanley AY, Durham CO, Sterrett JJ, Wallace JB (2019) Safety of over-the-counter medications in pregnancy. MCN Am J Matern Child Nurs 44(4):196–205. https://doi.org/10.1097/nmc.0000000000000537

    Article  PubMed  Google Scholar 

  57. FDA (2015) FDA drug safety communication: FDA has reviewed possible risks of pain medicine use during pregnancy. In: Drug safety and avaliability. Avaliable via: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy. Accessed Mar 2024

  58. NEURONTIN® (gabapentin) [package insert]. New York, NY: Pfizer Pharmaceuticals, Inc. December 2020

  59. LYRICA (pregabalin) [package insert]. New York, NY: Pfizer Pharmaceuticals Inc. 2020

  60. Patorno E et al (2020) Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US medicaid analytic eXtract dataset. PLoS Med 17(9):e1003322. https://doi.org/10.1371/journal.pmed.1003322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Mostacci B, Poluzzi E, D’Alessandro R, Cocchi G, Tinuper P (2018) Adverse pregnancy outcomes in women exposed to gabapentin and pregabalin: data from a population-based study. J Neurol Neurosurg Psychiatry 89(2):223–224. https://doi.org/10.1136/jnnp-2017-316143

    Article  PubMed  Google Scholar 

  62. Andrade C (2018) Safety of pregabalin in pregnancy. J Clin Psychiatry. https://doi.org/10.4088/JCP.18f12568

    Article  PubMed  Google Scholar 

  63. CDC (2022) Clinical considerations for use of recombinant zoster vaccine (RZV, Shingrix) in immunocompromised adults aged ≥ 19 years. In: Shingles (Herpes Zoster). Available via https://www.cdc.gov/shingles/vaccination/immunocompromised-adults.html. Accessed Mar 2024

Download references

Funding

This review was not funded.

Author information

Authors and Affiliations

  1. Rutgers New Jersey Medical School, Newark, NJ, USA

    Amit Singal

  2. Dermatology and Pathology, Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07103, USA

    Robert A. Schwartz & Chinmoy Bhate

Authors
  1. Amit Singal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chinmoy Bhate
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed significantly to the study conception and design. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Robert A. Schwartz.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

Not applicable.

Consent to publish

The authors affirm that the patient in this manuscript provided written informed consent for publication of the images 1–2.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singal, A., Schwartz, R.A. & Bhate, C. Herpes zoster infection in pregnancy: features and consequences. Arch Dermatol Res 316, 107 (2024). https://doi.org/10.1007/s00403-024-02842-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-024-02842-3

Keywords